- Report
- January 2026
Global
From €4286EUR$4,900USD£3,698GBP
- Report
- January 2026
Global
From €4286EUR$4,900USD£3,698GBP
- Report
- October 2025
Global
From €4286EUR$4,900USD£3,698GBP
- Report
- July 2025
Global
From €4286EUR$4,900USD£3,698GBP
From €4286EUR$4,900USD£3,698GBP
From €4286EUR$4,900USD£3,698GBP
- Report
- October 2025
- 150 Pages
Global
From €5204EUR$5,950USD£4,490GBP
- Report
- May 2025
- 200 Pages
Global
From €2178EUR$2,490USD£1,879GBP
- Report
- March 2025
- 200 Pages
Global
From €2178EUR$2,490USD£1,879GBP
- Report
- January 2026
- 184 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- January 2026
- 199 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- January 2026
- 197 Pages
Global
From €3445EUR$3,939USD£2,973GBP
- Report
- December 2025
- 200 Pages
Global
From €2615EUR$2,990USD£2,257GBP
- Report
- September 2025
- 250 Pages
Global
From €3927EUR$4,490USD£3,389GBP
- Report
- February 2026
- 377 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 182 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 371 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 271 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 296 Pages
Global
From €5117EUR$5,850USD£4,415GBP
- Report
- February 2026
- 183 Pages
Global
From €5117EUR$5,850USD£4,415GBP

The Inflammation market within the context of Allergy and Immunology is a rapidly growing field of research and development. It focuses on the study of the body's immune system and its response to allergens, pathogens, and other foreign substances. This includes the development of treatments and therapies to reduce inflammation and improve the body's ability to fight off infection. The market is driven by the increasing prevalence of allergies and autoimmune diseases, as well as the need for more effective treatments.
The Inflammation market is composed of a variety of companies, ranging from pharmaceuticals to biotechnology firms. These companies are focused on developing new treatments and therapies to reduce inflammation and improve the body's ability to fight off infection. Examples of companies in this market include AbbVie, AstraZeneca, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more